ARTICLE | Company News

Chiron, Aventis, National Institute of Allergy and Infectious Diseases deal

May 31, 2004 7:00 AM UTC

NIAID awarded contracts to both companies to manufacture 8,000 doses of a vaccine for the H5N1 influenza virus (avian) strain. AVE will manufacture the vaccines at its Aventis Pasteur facility in Swif...